Michael A. Hollingsworth

Affiliations: 
University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Biochemistry
Website:
https://www.unmc.edu/eppley/about/faculty/hollingsworth.html
Google:
"Michael Hollingsworth"
Bio:

https://books.google.com/books?id=pJYvAQAAIAAJ

Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Donald L. Evans grad student 1982 Wake Forest School of Medicine
 (Characterization of spleen cell proliferative responses, resistance to syngeneic tumor growth, and immunoregulatory activity in aging New Zealand black rats.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mundry CS, Triplett AA, Shah OS, et al. (2024) Single-cell RNA-sequencing of human spleens reveals an IDO-1 tolerogenic dendritic cell subset in pancreatic cancer patients that is absent in normal individuals. Cancer Letters. 607: 217321
Mullen NJ, Shukla SK, Thakur R, et al. (2024) DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation. Elife. 12
Kotwal A, Vance K, Hajric K, et al. (2024) Characterization of immune infiltrate along the leading edge of differentiated thyroid cancer. Thyroid : Official Journal of the American Thyroid Association
Zheng D, Grandgenett PM, Zhang Q, et al. (2024) radioGWAS links radiome to genome to discover driver genes with somatic mutations for heterogeneous tumor image phenotype in pancreatic cancer. Scientific Reports. 14: 12316
Murthy D, Attri KS, Shukla SK, et al. (2024) Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Nature Cell Biology
Murthy D, Attri KS, Suresh V, et al. (2024) The MUC1-HIF-1α signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling. Proceedings of the National Academy of Sciences of the United States of America. 121: e2315509121
Mack KN, Samuels ZV, Carter LM, et al. (2024) Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Murthy D, Attri KS, Shukla SK, et al. (2024) Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Nature Cell Biology
Aguilar EN, Sagar S, Murray BR, et al. (2024) Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6. Molecular Cancer Therapeutics
Dailey KM, Small JM, Pullan JE, et al. (2023) An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic. Plos One. 18: e0289183
See more...